危重症儿科患者与新型冠状病毒2型感染
Critically Ill Pediatric Patient and SARS-CoV-2 Infection.
作者信息
Klučka Jozef, Klabusayová Eva, Kratochvíl Milan, Musilová Tereza, Vafek Václav, Skříšovská Tamara, Kosinová Martina, Havránková Pavla, Štourač Petr
机构信息
Department of Paediatric Anaesthesiology and Intensive Care Medicine, University Hospital Brno and Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic.
Department of Simulation Medicine, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic.
出版信息
Children (Basel). 2022 Apr 11;9(4):538. doi: 10.3390/children9040538.
Abstract
In December 2019 SARS-CoV-2 initiated a worldwide COVID-19 pandemic, which is still ongoing in 2022. Although adult elderly patients with chronic preexisting diseases had been identified as the most vulnerable group, COVID-19 has also had a significant impact on pediatric intensive care. Early in 2020, a new disease presentation, multisystemic inflammatory syndrome, was described in children. Despite the vaccination that is available for all age categories, due to its selection process, new viral mutations and highly variable vaccination rate, COVID-19 remains a significant clinical challenge in adult and pediatric intensive care in 2022.
摘要
2019年12月，严重急性呼吸综合征冠状病毒2引发了全球新型冠状病毒肺炎大流行，这一疫情在2022年仍在持续。尽管患有慢性基础疾病的成年老年患者被确定为最脆弱群体，但新型冠状病毒肺炎对儿科重症监护也产生了重大影响。2020年初，在儿童中描述了一种新的疾病表现——多系统炎症综合征。尽管所有年龄段都可接种疫苗，但由于其选择过程、新的病毒突变以及疫苗接种率差异很大，新型冠状病毒肺炎在2022年仍然是成人和儿科重症监护中的一项重大临床挑战。
相似文献
1
Critically Ill Pediatric Patient and SARS-CoV-2 Infection.危重症儿科患者与新型冠状病毒2型感染
Children (Basel). 2022 Apr 11;9(4):538. doi: 10.3390/children9040538.
2
Comparison of Clinical Findings in SARS-CoV-2 with Other Respiratory Viruses in Critically Ill Children during the COVID-19 Pandemic.COVID-19 大流行期间危重症儿童中 SARS-CoV-2 与其他呼吸道病毒的临床特征比较。
J Trop Pediatr. 2021 Dec 8;67(6). doi: 10.1093/tropej/fmab102.
3
Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.儿童和青少年中严重的 SARS-CoV-2 表现：从 COVID-19 肺炎到多系统炎症综合征：西班牙儿科重症监护病房的一项多中心研究。
Crit Care. 2020 Nov 26;24(1):666. doi: 10.1186/s13054-020-03332-4.
4
Establishment of a pediatric COVID-19 biorepository: unique considerations and opportunities for studying the impact of the COVID-19 pandemic on children.建立儿科 COVID-19 生物库：研究 COVID-19 大流行对儿童影响的独特考虑因素和机会。
BMC Med Res Methodol. 2020 Sep 11;20(1):228. doi: 10.1186/s12874-020-01110-y.
5
COVID-19 in Children and Adolescents: Characteristics and Specificities in Immunocompetent and Oncohematological Patients.儿童和青少年中的COVID-19：免疫功能正常和肿瘤血液学患者的特征及特异性
Mediterr J Hematol Infect Dis. 2022 Jan 1;14(1):e2022009. doi: 10.4084/MJHID.2022.009. eCollection 2022.
6
Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea.韩国2019冠状病毒病儿科患者的特征。
J Korean Med Sci. 2021 May 24;36(20):e148. doi: 10.3346/jkms.2021.36.e148.
7
How pediatric resident's life has changed during the COVID-19 pandemic.儿科住院医师的生活在 COVID-19 大流行期间发生了怎样的变化。
Ital J Pediatr. 2020 Oct 16;46(1):156. doi: 10.1186/s13052-020-00920-6.
8
Shock and Myocardial Injury in Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection: What We Know. Case Series and Review of the Literature.儿童感染 SARS-CoV-2 相关多系统炎症综合征中的休克与心肌损伤：我们已知的情况。病例系列及文献回顾。
J Intensive Care Med. 2021 Apr;36(4):392-403. doi: 10.1177/0885066620969350. Epub 2020 Nov 5.
9
Prospective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: a national cohort study.2020年澳大利亚三级儿科医院就诊儿童中新型冠状病毒感染的前瞻性特征分析：一项全国队列研究
BMJ Open. 2021 Nov 8;11(11):e054510. doi: 10.1136/bmjopen-2021-054510.
10
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
引用本文的文献
1
COVID-19-Associated Paediatric Inflammatory Multisystem Syndrome (PIMS-TS) in Intensive Care: A Retrospective Cohort Trial (PIMS-TS INT).重症监护中的新冠病毒相关儿童炎性多系统综合征（PIMS-TS）：一项回顾性队列试验（PIMS-TS INT）
Children (Basel). 2023 Feb 10;10(2):348. doi: 10.3390/children10020348.
2
Causes of Intensive Care Unit Admissions in Children with SARS-CoV-2: A Single-Centre Observational Study.2019冠状病毒病患儿入住重症监护病房的原因：一项单中心观察性研究
Children (Basel). 2022 Dec 30;10(1):75. doi: 10.3390/children10010075.
3
Paediatric Deep Neck Infection-The Risk of Needing Intensive Care.小儿深部颈部感染——需要重症监护的风险
Children (Basel). 2022 Jun 29;9(7):979. doi: 10.3390/children9070979.
本文引用的文献
1
Clinical care of children and adolescents with COVID-19: recommendations from the National COVID-19 Clinical Evidence Taskforce.儿童和青少年 COVID-19 的临床护理：国家 COVID-19 临床证据工作组的建议。
Med J Aust. 2022 Mar 21;216(5):255-263. doi: 10.5694/mja2.51305. Epub 2021 Oct 24.
2
Pediatric Patient with Ischemic Stroke: Initial Approach and Early Management.小儿缺血性卒中患者：初始评估与早期管理
Children (Basel). 2021 Jul 28;8(8):649. doi: 10.3390/children8080649.
3
Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): a narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee.儿童炎症性多系统综合征与 COVID-19 相关（PIMS-TS）：叙述性综述及拉丁美洲小儿重症监护学会（SLACIP）脓毒症委员会的观点。
BMJ Paediatr Open. 2021 Feb 4;5(1):e000894. doi: 10.1136/bmjpo-2020-000894. eCollection 2021.
4
Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children.与儿童 COVID-19 重症相关的基础医学状况。
JAMA Netw Open. 2021 Jun 1;4(6):e2111182. doi: 10.1001/jamanetworkopen.2021.11182.
5
Multisystem Inflammatory Syndrome Associated with COVID-19 Anti-thrombosis Guideline of Care for Children by Action.与COVID-19相关的儿童多系统炎症综合征抗血栓形成行动护理指南
Pediatr Cardiol. 2021 Oct;42(7):1635-1639. doi: 10.1007/s00246-021-02651-9. Epub 2021 Jun 2.
6
European Resuscitation Council Guidelines 2021: Paediatric Life Support.欧洲复苏委员会指南 2021：儿科生命支持。
Resuscitation. 2021 Apr;161:327-387. doi: 10.1016/j.resuscitation.2021.02.015. Epub 2021 Mar 24.
7
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.COVID-19 重症患者的白细胞介素 6 受体拮抗剂。
N Engl J Med. 2021 Apr 22;384(16):1491-1502. doi: 10.1056/NEJMoa2100433. Epub 2021 Feb 25.
8
SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions.SARS-CoV-2，SARS-CoV 和 MERS-CoV 的另一面：未来预测。
Biomed J. 2021 Mar;44(1):86-93. doi: 10.1016/j.bj.2020.10.008. Epub 2020 Oct 28.
9
Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics.儿童感染新冠病毒相关多系统炎症综合征（MIS-C）：意大利儿科学会风湿病学研究组的诊断和治疗指南。
Ital J Pediatr. 2021 Feb 8;47(1):24. doi: 10.1186/s13052-021-00980-2.
10
Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.静脉注射免疫球蛋白联合甲泼尼龙与单独使用免疫球蛋白治疗儿童多系统炎症综合征发热病程的关联。
JAMA. 2021 Mar 2;325(9):855-864. doi: 10.1001/jama.2021.0694.
Zotero 插件